Intravenous injection of non-neurotoxic plasminogen activators for the treating of stroke

Details for Australian Patent Application No. 2004233601 (hide)

Owner Paion Deutschland GmbH

Inventors Sohngen, Wolfgang; Schleuning, WolfDieter; Medcalf, Robert; Sohngen, Mariola

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004233601

PCT Pub. Number WO2004/096268

Priority PCT/EP03/04608 02.05.03 EP; PCT/EP03/04729 06.05.03 EP

Filing date 30 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 26 November 2009

International Classifications

A61K 38/49 (2006.01) Medicinal preparations containing peptides

A61K 38/58 (2006.01) Medicinal preparations containing peptides

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/096268 Priority application(s): WO2004/096268

26 November 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Intravenous injection of nonneurotoxic plasminogen activators for the treating of stroke

26 November 2009 Application Accepted

  Published as AU-B-2004233601

25 March 2010 Standard Patent Sealed

28 June 2012 Assignment Registered

  Paion Deutschland GmbH The patent has been assigned to H. Lundbeck A/S

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233603-Human serum albumin-free stabilized interferon liquid formulations

2004233597-Angiotensin II receptor blockers for preventing the development or progression of microvascular disease due to diabetes